Pickering, G. : Hypertension. Definitions, natural histories and consequences. Amer. J. Med., 52: 570, 1972.
2.
Stamler, J., Schonberger, J.A., Shekelle, R.B. and Stamler, R.: Hypertension, the problem and the challenge. In the Hypertension Handbook, p. 3. Merck. Sharp & Dohme, West Point, 1974.
3.
Julius, S. and Schork, M.A.: Borderline Hypertension—A critical review. J. Chron. Dis., 23: 723, 1971.
4.
Evelyn, K.A. : A long-term study of the natural history of essential hypertension. Ann. Int. Med., 33: 629, 1950.
5.
Widimsky, J. , Fejfarova, M.H. and Fejfar, Z.: Changes of cardiac output in hypertensive disease. Cardiologia (Basel), 31: 381, 1957.
6.
Eich, R.H., Cuddy, R.P., Smulyan, H. and Lyons, R.H.: Hemodynamics in labile hypertension: a follow-up study. Circulation , 34: 299, 1966.
7.
Sannerstedt, R., Julius, S. and Conway, J.: Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation, 42: 1057, 1970.
8.
Frohlich, E.D. , Kozul, V.J., Tarazi, R.C. and Dustan, H.P.: Physiological comparison of labile and essential hypertension. Circul. Res., 26-27/I: 55, 1970.
Julius, S., Pascual, A.V. and London, R.: Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation, 44: 413, 1971.
11.
Gordon, R.D., Kuchel, O., Liddle, G.W. and Island, D.P.: Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J. Clin. Invest., 46: 599, 1967.
12.
Winer, N., Chokshi, D.S., Yoon, M.S. and Freedman, A.D.: Adrenergic receptor mediation of renin secretion. J. Clin. Endocr., 29: 1168, 1969.
13.
Ganong, W.F.: Effects of sympathetic activity and ACTH on renin and aldosterone secretion . In: Hypertension '72, p. 4. editors J. Genest and Koiw, E.Springer-Verlag, Berlin, Heidelberg , New York, 1972.
14.
Robison, G.A. , Butcher, R.W. and Sutherland , E.W.: Adenyl cyclase as an adrenergic receptor. Ann. N. Y. Acad. Sci., 139: 703, 1967.
15.
Michelakis, A.M., Caudle, J. and Liddle, G.W.: In vitro stimulation of renin production by epinephrine, norepinephrine and cyclic AMP. Proc. Soc. Exp. Biol. (N.Y.), 130: 748. 1969.
16.
Winer, N., Chokshi, D.S. and Walkenhorst, W.G. : Effects of cyclic AMP, sympathomimetic amines and adrenergic receptor antagonists on reoin secretion. Circulat. Res., 29: 239, 1871.
17.
Kuchel, O., Hamet, P., Tolis, G., Fraysse, J., Trachewsky, D. and Genest, J.: Adenosine 3':5'-cyclic monophosphate in human hypertension. "The Nervous System in Arterial Hypertension", S. Julius and M. Esler, editors. C. CThomas. Springfield, III.1975.
18.
Cuche, J.L. , Kuchel, O., Barbeau, A., Langlois, Y., Boucher, R., Genest, J.: Autonomic nervous system and benign essential hypertension in man. I. Usual blood pressure, catecholamines, renin and their interrelationships. Circulation Research, 35: 281, 1974.
19.
Von Euler, U.S., Hellner, S. and Purkhold, A.: Excretion of noradrenaline in urine in hypertension . Scand. J. Clin. Lab. Invest., 6: 54, 1954.
20.
Serrano, P.A. , Figueroa, G., Torres, M. and Del Angel, A.R.: Adrenaline, noradrenaline and dopamine excretion in patients with essential hypertension. Amer. J. Cardiol., 13: 484, 1964.
21.
Moller, P., Buus, O. and Bierring, E.: Blood pressure and urinary excretion of nor-adrenaline. (NA)Scand. J. Clin. Lab. Invest., 9: 331, 1957.
22.
Brunjes, S. : Catecholamine metabolism in essential hypertension . New Engl. J. Med., 271: 20, 1964.
23.
Goodall, McC. and Bogdonoff, M.: Essential hypertension with an elevated noradrenaline excretion. Amer. Heart J., 61: 640, 1961.
24.
DeQuattro, V. and Sjoerdsma, A.: Catecholamine turnover in normotensive and hypertensive man: effects of antiadrenergic drugs. J. Clin. Invest., 47: 2359, 1968.
25.
Sourkes, T.L. , and Murphy, G.F.: Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry. Meth. med. Res., 9: 147, 1961.
26.
Sato, T.L.: The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine. J. Lab. Clin. Med., 66: 517, 1965.
27.
Anton, A.H. and Sayre, D.F.: A study of the factors affecting the aluminum oxide trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther., 138: 360, 1962.
28.
Boucher, R. , Veyrat, R., DeChamplain, J. and Genest, J.: New procedure for measurements of human plasma angiotensin and renin activity levels. Canad. Med. Ass. J. , 90: 194, 1964.
29.
Cuche, J.L. , Kuchel, O., Barbeau, A. and Genest, J.: Urinary excretion of homovanillic acid in benign essential hypertension, a biochemical marker of labile hypertension . Canad. Med. Ass. J. accepted for publication 1975.
30.
Cuche, J.L. , Kuchel, O., Barbeau, A., Hamet, P., Boucher, R. and Genest, J.: Système nerveux adrénergique et hypertension artérielle essentielle. Union Méd. Canada, 102: 812, 1973.
31.
Louis, W.J. , Doyle, A.E. and Anaveka, S.: Plasma norepinephrine levels in essential hypertension. New Engl. J. Med., 288: 599, 1973 .
32.
Guyton, A.C. , Coleman, T.G., Cowley, A.W., Scheel, K.W., Manning, R.D. Jr., and Norman , R.A. Jr.: Arterial pressure regulation. Overriding dominance of the kidneys in longterm regulation and in hypertension. Amer. J. Med., 52: 584, 1972.
33.
Kuchel, O., Cuche, J.L., Hamet, P., Barbeau, A., Boucher, R. and Genest, J.: Catecholamines, cyclic adenosine monophosphate and renin in labile hypertension . In: Mechanisms of hypertension, p. 160. M. P. Sambhi, editor. Amsterdam, Excerpta Medica, 1973.
34.
Kuchel, O., Cuche, J.L., Hamet, P., Boucher, R., Barbeau, A. and Genest, J.: The relationship between adrenergic nervous system and renin in labile hyperkinetic hypertension. In: "Hypertension '72", p. 118. J. Genest and E. Koiw, editors. Springer-Verlag, Berlin, Heidelberg, New York, 1972.
35.
Esler, M.D. and Nestel, P.J.: Sympathetic responsiveness to head-up tilt in essential hypertension. Clin. Sci., 44: 213, 1973.
36.
Frohlich, E.D. , Tarazi, R.C., Ulrych, M., Dustan, H.P. and Page, I.H.: Tilt test for investigating a neural component in hypertension: its correlation with clinical characteristics. Circulation, 36: 387, 1967.
37.
Braunwald, E. : Regulation of the circulation, New Engl. J. Med., 290: 1124, 1974.
38.
Safar, M.E., Weiss, Y.A., Levenson, J.A., London, G.M., Milliez, P.L.: Hemodynamic study of 85 patients with borderline hypertension. Amer. J. Cardiol., 31: 315, 1973.
39.
Ellis, C.N. and Julius, S.: Role of central blood volume in hyperkinetic borderline hypertension. Brit. Heart J., 35: 450, 1973.
40.
Dairman, W., Gordon, R., Spector, S., Sjoerdsma, A., and Udenfriend, S.: Increased synthesis of catecholamines in the intact rat following administration of α-adrenergic blocking agents. Mol. Pharmacol., 4: 457, 1968.
41.
Robison, G.A. , Butcher, R.W. and Sutherland , E.W.: Cyclic AMP. New York and London, Academic Press, 1971.
42.
Hamet, P., Kuchel, O. and Genest. J.: Effect of upright posture and isoproterenol infusion on cyclic adenosine monophosphate excretion in control subjects and patients with labile hypertension. J. Clin. Endocr. Metab., 36: 218, 1973.
43.
Hamet, P., Kuchel, O., Fraysse, J. and Genest, J.: Plasma adenosine 3':5'-cyclic monophosphate in human hypertension. Canad. Med. Ass. J., 111: 323, 1974.
44.
Hamet, P., Kuchel, O., Cuche, J.L., Boucher, R. and Genest, J.: Effect of propranolol on cyclic AMP excretion and plasma renin activity in labile essential hypertension. Canad. Med. Ass. J., 109: 1099, 1973.
45.
Messerli, F.H. , Kuchel, O., Tolis, G., Hamet, P., Fraysse, J. and Genest. J.: Clin. Res.23: 1975 (abstract) to be published.
46.
DeQuattro, V. and Miura, Y.: Neurogenic factors in human hypertension: mechanism or myth?Amer. J. Med., 55: 362, 1973.
47.
Charvat, J. , Dell, P. and Folkow, B.: Mental factors and cardiovascular diseases . Cardiologia, 44: 124, 1964.
48.
DeQuattro, V.: Evaluation of increased norepinephrine excretion in hypertension using L-Dopa-3H. Circ. Res., 28: 84, 1971.
49.
Gitlow, S.E. , Mendlowitz, M., Wilk, E.K., Wilk, S., Wolf, R.L. and Naftchi, N.E.: Plasma clearance of dl-β-3H norepinephrine in normal human subjects and patients with essential hypertension. J. Clin. Invest., 43: 2009, 1964.
50.
Engelman, K. , Portnoy, B.: A sensitive double isotope derivative assay for norepinephrine and epinephrine: normal resting human plasma levels. Circ. Res., 26: 53, 1970.
51.
Christensen, N.J.: Increased levels of plasma noradrenaline in hypothyroidism. J. Clin. Endocr., 35: 359, 1972.
52.
Karlberg, B.E. , Henriksson, K.G., Andersson, R.G.G.: Cyclic adenosine 3',5'-monophosphate concentration in plasma, adipose tissue and skeletal muscle in normal subjects and in patients with hyper- and hypothyroidism. J. Clin. End. Metab., 39: 96, 1974.
53.
Hartrodt, W. , Brosowski, K.H., Kreher, C., Graff, Ch. , Ziprian, H. and Baumann, R.: Die Plasmarenin-Aktivitat bei exogener Belastung von essentiellen Hypertonikern und Normotonikern. Acta Biol. Med. Germ., 26: 1013, 1971.
54.
Galdwell, J.R. and Carretero, O.A.: Plasma renin and blood pressure after sympathetic stimulation in normotensive and hypertensive patients. Amer. J. Cardiol., 29: 466, 1972.
55.
Nowaczynski, W., Kuchel, O., Genest, J., Messerli, F.H., Honda, M., Tolis, G., Parvin-Pande, R., Kubo, S., Grose, J. and Lebel, M.: Dynamic aldosterone and 18-hydroxydeoxycorticosterone studies in labile and stable benign essential hypertension. Presented at the fourth Intern. Congr. on Hormonal Steroids, 2-7 September1974 , Mexico, Mexico. To be published in J. Ster. Biochem.